بحث علمي

Ripasudil, a Rho kinase inhibitor, attenuates testosterone-induced benign prostatic hyperplasia in rats: targeting inflammation, oxidative stress, and Rho kinase pathways

Naunyn-Schmiedeberg's Archives of Pharmacology, 1-15, 2025